Latest Breaking News On - Relmada therapeutics inc - Page 1 : comparemela.com

AdvisorShares Investments LLC Has $309,000 Position in Relmada Therapeutics, Inc (NASDAQ:RLMD)

AdvisorShares Investments LLC cut its stake in shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD – Free Report) by 33.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 74,666 shares of the company’s stock after selling 38,242 shares during the period. AdvisorShares Investments LLC owned 0.25% of […]

United statesRelmada therapeutics incMirae asset global investments coAdvisorshares investmentsGuild investment management incSilverarc capital managementGoldman sachs groupRelmada therapeuticsFree reportShares investmentsCapital managementInvestment managementMirae asset global investmentsAsset global investmentsGet free reportRelmada therapeutics daily

Q2 2024 Earnings Estimate for Relmada Therapeutics, Inc (NASDAQ:RLMD) Issued By Leerink Partnrs

Q2 2024 Earnings Estimate for Relmada Therapeutics, Inc (NASDAQ:RLMD) Issued By Leerink Partnrs
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesLeerink partnrsSilverarc capital managementOpaleye management incRelmada therapeutics incParsons capital management incGuild investment management incRelmada therapeuticsFree reportRelmada therapeuticGet free reportPoint capitalCapital managementGuild investment managementInvestment managementRelmada therapeutics daily

Relmada Therapeutics (RLMD) Set to Announce Earnings on Wednesday

Relmada Therapeutics (RLMD) Set to Announce Earnings on Wednesday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesRelmada therapeutics incRelmada therapeuticsGet free reportRelmada therapeutics daily

Relmada Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024

CORAL GABLES, Fla., May 6, 2024 /PRNewswire/ Relmada Therapeutics, Inc. , a late-stage biotechnology company addressing diseases of the central nervous system , today announced that it will.

Tim mccarthyPrnewswire relmada therapeutics incCorporate communicationsRelmada therapeutics incSecurities exchangeConference callRelmada therapeuticsPrivate securities litigation reform actSecurities actSecurities exchange act

Parsons Capital Management Inc RI Sells 24,241 Shares of Relmada Therapeutics, Inc (NASDAQ:RLMD)

Parsons Capital Management Inc. RI reduced its stake in Relmada Therapeutics, Inc. (NASDAQ:RLMD – Free Report) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 949,841 shares of the company’s stock after selling 24,241 shares during […]

Maged shenoudaBlackrock incParsons capital management incRelmada therapeutics incRenaissance technologiesExchange commissionMillennium managementParsons capital managementRelmada therapeuticsFree reportCapital managementAlto investorsSigma investmentsChuck enceRelmada therapeutics dailyNasdaq rlmd